Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06843213

Teaching Health Promotion and Resilience in Varied Environments: a Peer-led Intervention Following Hospital Discharge

Led by University of Pennsylvania · Updated on 2026-02-27

390

Participants Needed

3

Research Sites

17 weeks

Total Duration

On this page

Sponsors

U

University of Pennsylvania

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a peer-led health resilience and promotion program called the THRIVE intervention for people with opioid use disorder. The study aims to find out if participants receiving the THRIVE intervention have fewer self-reported non-fatal overdoses or skin and soft tissue infections compared to those receiving enhanced usual care. The study is sponsored by the University of Pennsylvania and focuses on support following hospital discharge. Participants in the THRIVE intervention group will receive one in-person session from a peer support specialist while in the hospital, followed by weekly text messages for 12 weeks. They will also answer monthly multiple-choice assessments via text at months 1 through 6. Participants in the enhanced usual care group will receive a handout with health resilience education and local resources and will complete the same monthly text assessments. Both groups will complete baseline, 3-month, and 6-month assessments with research assistants. Throughout the study, participants will be monitored through self-reported surveys and assessments to track the incidence of non-fatal overdoses and skin or soft tissue infections. The primary outcome compares these outcomes from baseline to 6 months between the two groups. Participants will be evaluated at multiple time points, with data collected via text messages and in-person assessments, allowing researchers to measure the effectiveness of the THRIVE intervention over half a year.

CONDITIONS

Brief Title

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants admitted to specified UPMC hospitals or seen in the UPMC emergency departments
  • Current diagnosis of Opioid Use Disorder based on DSM-5 criteria
  • At least 18 years of age on day of admission
  • Able to speak and read English
Not Eligible

You will not qualify if you...

  • Diagnosis of dementia or cognitive impairments
  • Acute psychiatric complications such as schizophrenia with acute psychosis, acute mania, or suicidal ideation
  • Pregnant or lactating at study start
  • Cannot read or speak English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 12 weeks

Participants receive either a peer-led, in-person session with weekly text message support over 12 weeks or enhanced usual care through educational handouts.

1 in-person session and weekly text messages over 12 weeks

Follow-up

Duration - Up to 6 months

Participants are monitored for health outcomes including incidence of non-fatal overdoses and skin and soft tissue infections up to 6 months.

Visits as scheduled for outcome assessments

Trial Site Locations

Total: 3 locations

1

UPMC Mercy Hospital

Pittsburgh, Pennsylvania, United States, 15203

Not Yet Recruiting

2

UPMC Presbyterian-Montefiore Hospital

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

3

UPMC Shadyside Hospital

Pittsburgh, Pennsylvania, United States, 15232

Not Yet Recruiting

Loading map...

Research Team

R

Research Program Coordinator

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

A Bundled Intervention to End Opioid Overdose by Increasing ...

Opioid Use Disorder

Actively Recruiting

1 location

A Randomized Controlled Trial Examining Extended-Release Inj...

Opioid Use Disorder

Actively Recruiting

1 location

A Comparative Study of Fruit Stand Availability and Awarenes...

Dietary Behaviors

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.

Samuel R Friedman, Wouter de Jong, Diana Rossi...

https://pubmed.ncbi.nlm.nih.gov/17689353

A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs.

Kristina T Phillips, Catherine Stewart, Bradley J Anderson...

https://pubmed.ncbi.nlm.nih.gov/33677353

Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.

Amina Moustaqim-Barrette, Damon Dhillon, Justin Ng...

https://pubmed.ncbi.nlm.nih.gov/33771150

Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.

Susan G Sherman, Kenneth B Morales, Ju Nyeong Park...

https://pubmed.ncbi.nlm.nih.gov/30991301

Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.

Jacqueline E Goldman, Katherine M Waye, Kobe A Periera...

https://pubmed.ncbi.nlm.nih.gov/30621699